The proposed research is committed to the further understanding of the neuronal bases of dependence to the abused opiates and cocaine. Previous work has indicated that there are protracted effects weeks after the last of a few high doses of morphine, therefore focus will be on the elucidation of these changes with cocaine as well as opiates using the quantitative 2-deoxy-D-[l-14C]glucose (2-DG) for the determination of local cerebral metabolic utilization of glucose. Because these effects were enhanced by conditioned drug cues the proposed experiments will explore in detail the effects of these conditioned cues on the protracted effects. In addition, experiments will be carried out to determine the role of the excitatory amino acids on the expression of these protracted drug effects as well as the role of GABA, adenosine, dopamine Dl receptor, and cyclic AMP systems in modulating the rewarding effects and intake of both cocaine and heroin. The experiments, taken together, will allow for the further understanding of the role of the brain reward system in mediating both the acute and protracted effects of abused substances. These protracted effects, present long after cessation of drug administration, have major importance for the understanding of the phenomenon of craving. With this knowledge effective therapies may be rationally developed. In addition to the 2-DG procedure the experiments will employ drug self- administration, brain-stimulation reward, and conditioned place preference, all models used to study the rewarding effects of abused substances. The experimental animal will be the rat.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Scientist Award (K05)
Project #
5K05DA000099-19
Application #
6475959
Study Section
Special Emphasis Panel (ZDA1-MXS-M (09))
Program Officer
Wetherington, Cora Lee
Project Start
1993-12-10
Project End
2003-11-30
Budget Start
2001-12-15
Budget End
2002-11-30
Support Year
19
Fiscal Year
2002
Total Cost
$117,515
Indirect Cost
Name
Boston University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Kornetsky, Conan; Knapp, Clifford M; Tozier, Lisa et al. (2010) Medial forebrain stimulation enhances intracranial nociception and attenuates morphine analgesia suggesting the existence of an endogenous opioid antagonist. Pharmacol Biochem Behav 95:273-7
Knapp, Clifford M; Tozier, Lisa; Pak, Arlene et al. (2009) Deep brain stimulation of the nucleus accumbens reduces ethanol consumption in rats. Pharmacol Biochem Behav 92:474-9
Vassoler, Fair M; Schmidt, Heath D; Gerard, Mary E et al. (2008) Deep brain stimulation of the nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug seeking in rats. J Neurosci 28:8735-9
Knapp, Clifford M; Mercado, Melissa; Markley, Tara Lynn et al. (2007) Zonisamide decreases ethanol intake in rats and mice. Pharmacol Biochem Behav 87:65-72
Crosby, Steven J; Knapp, Clifford M; Kornetsky, Conan (2006) Nociceptive threshold and analgesic response to morphine in aged and young adult rats as determined by thermal radiation and intracerebral electrical stimulation. Pharmacol Biochem Behav 84:148-57
Jha, Shivkumar H; Knapp, Clifford M; Kornetsky, Conan (2004) Effects of morphine on brain-stimulation reward thresholds in young and aged rats. Pharmacol Biochem Behav 79:483-90
Knapp, Clifford M; Jha, Shivkumar H; Kornetsky, Conan (2004) Increased sensitization to morphine-induced oral stereotypy in aged rats. Pharmacol Biochem Behav 79:491-7
Gill, Brian M; Knapp, Clifford M; Kornetsky, Conan (2004) The effects of cocaine on the rate independent brain stimulation reward threshold in the mouse. Pharmacol Biochem Behav 79:165-70
Knapp, Clifford M; Printseva, Bella; Cottam, Nicole et al. (2002) Effects of cue exposure on brain glucose utilization 8 days after repeated cocaine administration. Brain Res 950:119-26
Knapp, C M; Foye, M M; Cottam, N et al. (2001) Adenosine agonists CGS 21680 and NECA inhibit the initiation of cocaine self-administration. Pharmacol Biochem Behav 68:797-803

Showing the most recent 10 out of 26 publications